Citigroup Inc P Lx Pharma Inc. Transaction History

Citigroup Inc

  • $150 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$3.54 - $8.3 $16,984 - $39,823
-4,798 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$7.69 - $19.66 $21,301 - $54,458
2,770 Added 136.59%
4,798 $38,000
Q3 2021

Nov 10, 2021
BUY
$12.22 - $21.28 $24,782 - $43,155
2,028 New
2,028 $39,000

Others Institutions Holding PLXP

# of Institutions
4
Shares Held
61.6K
Call Options Held
0
Put Options Held
0
View Full List

About PLx Pharma Inc.

PLXP Quotes by TradingView
  • Ticker PLXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,137,700
  • Description
  • PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...
More about PLXP
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email